TriNetX’s Post

Listen to what new data from the #ASCO24 congress is likely to impact the field of upper GI oncology. With experts Sam Klempner and Lizzy Smyth. Watch this space for a summary of the highlights during the congress. #MedEd #MedEd #MedicalEducation

Today, we announced a poster presentation at the American Society of Clinical Oncology (ASCO)) annual meeting highlighting interim results from the ongoing Phase 1 ELiPSE-1 study of CNTY-101 in relapsed or refractory (R/R) #lymphoma. The poster showcases CNTY-101’s continued encouraging preliminary efficacy and manageable safety profile for with no observed DLTs or GvHD. Learn more: https://bit.ly/3RaEI3k #ASCO2024

The Scientific Program Committee and American Society of Clinical Oncology (ASCO) Leadership selected our Trials in Progress abstract for presentation in a poster session! Meet our team to discuss our ongoing clinical trial. Date and Time: Saturday, June 1, 9:00 AM - 12:00 PM Abstract Number: TPS3171 Abstract Title: A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of TT125-802 in patients with advanced solid tumors. #ASCO24 #StoppingCancerDrugResistance

A week has passed since ESMO 2024! What were your highlights? Check out Diaceutics PLC's article summarizing some key advancements for precision oncology: https://lnkd.in/e9FHHjnf #ESMO24 #BetterTestingBetterTreatment

#oncology https://lnkd.in/gpd3J-Bg Abstract presentation at the Young leaders in Oncology session.

Regarding our participation in the 3rd International Conference on Contemporary Oncology 

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech

In the next blog in our oncology series, Parexel experts outline a proven 4-part approach to understanding and integrating the patient perspective and how it can guide study design and improve outcomes. Our dedicated team of Biotech experts will amplify your team’s expertise to help you uncover insights faster to impact patient lives. Let’s change lives together. #OncologyResearch #PatientPerspective #ClinicalTrials #ParexelBiotech